Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT07300241
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
- Locations
-
- NEO-811 Los Angeles Site Duarte, California, United States
- NEO-811 San Diego Site San Diego, California, United States
- NEO-811 Connecticut Site New Haven, Connecticut, United States
- NEO-811 Chicago Site Zion, Illinois, United States
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
NCT05917106
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China Nanjing, Jiangsu, China
NCT05931393
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
NCT06682793
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +57 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- UCSD Moores Cancer Center La Jolla, California, United States
- UCLA Medical Center Los Angeles, California, United States
- Mayo Clinic Jacksonville, Florida, United States
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
NCT06259552
- Conditions
- CRC, Carcinoma, Carcinoma, Squamous Cell, +9 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
NCT07689812
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Advanced Solid Tumors Cancer, +54 more
- Locations
-
Not specified
NCT07324876
- Conditions
- RCC
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
NCT06585878
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
Not specified
Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
NCT06577961
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
Not specified
NCT03891485
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- IRCCS Istituto Nazionale Tumori di Napoli Naples, Italy
NCT03652077
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +96 more
- Locations
-
- The Angeles Clinical and Research Institute Los Angeles, California, United States
- University of Mississippi Jackson, Mississippi, United States
- Hackensack Medical Center Hackensack, New Jersey, United States
- Carolina BioOncology Huntsville, North Carolina, United States
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
NCT02974738
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Astrocytoma, +39 more
- Locations
-
Not specified
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)
NCT02293980
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Yale School of Medicine New Haven, Connecticut, United States
- University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States